Trigger point injections for headache disorders: Expert consensus methodology and narrative review

Matthew S. Robbins, Deena Kuruvilla, Andrew Blumenfeld, Larry Charleston, Michael Sorrell, Carrie E. Robertson, Brian M. Grosberg, Steven D. Bender, Uri Napchan, Avi Ashkenazi

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Objective/Background To review the existing literature and describe a standardized methodology by expert consensus for the performance of trigger point injections (TPIs) in the treatment of headache disorders. Despite their widespread use, the efficacy, safety, and methodology of TPIs have not been reviewed specifically for headache disorders by expert consensus. Methods The Peripheral Nerve Blocks and Other Interventional Procedures Special Interest Section of the American Headache Society over a series of meetings reached a consensus for nomenclature, indications, contraindications, precautions, procedural details, outcomes, and adverse effects for the use of TPIs for headache disorders. A subcommittee of the Section also reviewed the literature. Results Indications for TPIs may include many types of episodic and chronic primary and secondary headache disorders, with the presence of active trigger points (TPs) on physical examination. Contraindications may include infection, a local open skull defect, or an anesthetic allergy, and precautions are necessary in the setting of anticoagulant use, pregnancy, and obesity with unclear anatomical landmarks. The most common muscles selected for TPIs include the trapezius, sternocleidomastoid, and temporalis, with bupivacaine and lidocaine the agents used most frequently. Adverse effects are typically mild with careful patient and procedural selection, though pneumothorax and other serious adverse events have been infrequently reported. Conclusions When performed in the appropriate setting and with the proper expertise, TPIs seem to have a role in the adjunctive treatment of the most common headache disorders. We hope our effort to characterize the methodology of TPIs by expert opinion in the context of published data motivates the performance of evidence-based and standardized treatment protocols.

Original languageEnglish (US)
Pages (from-to)1441-1459
Number of pages19
JournalHeadache
Volume54
Issue number9
DOIs
StatePublished - Oct 1 2014

Fingerprint

Trigger Points
Headache Disorders
Injections
Secondary Headache Disorders
Primary Headache Disorders
Superficial Back Muscles
Nerve Block
Bupivacaine
Expert Testimony
Pneumothorax
Clinical Protocols
Lidocaine
Peripheral Nerves
Terminology
Skull
Anticoagulants
Patient Selection
Physical Examination
Anesthetics
Hypersensitivity

Keywords

  • headache
  • local anesthetic
  • migraine
  • myofascial pain
  • tension-type
  • trigger point injection

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Robbins, M. S., Kuruvilla, D., Blumenfeld, A., Charleston, L., Sorrell, M., Robertson, C. E., ... Ashkenazi, A. (2014). Trigger point injections for headache disorders: Expert consensus methodology and narrative review. Headache, 54(9), 1441-1459. https://doi.org/10.1111/head.12442

Trigger point injections for headache disorders : Expert consensus methodology and narrative review. / Robbins, Matthew S.; Kuruvilla, Deena; Blumenfeld, Andrew; Charleston, Larry; Sorrell, Michael; Robertson, Carrie E.; Grosberg, Brian M.; Bender, Steven D.; Napchan, Uri; Ashkenazi, Avi.

In: Headache, Vol. 54, No. 9, 01.10.2014, p. 1441-1459.

Research output: Contribution to journalArticle

Robbins, MS, Kuruvilla, D, Blumenfeld, A, Charleston, L, Sorrell, M, Robertson, CE, Grosberg, BM, Bender, SD, Napchan, U & Ashkenazi, A 2014, 'Trigger point injections for headache disorders: Expert consensus methodology and narrative review', Headache, vol. 54, no. 9, pp. 1441-1459. https://doi.org/10.1111/head.12442
Robbins MS, Kuruvilla D, Blumenfeld A, Charleston L, Sorrell M, Robertson CE et al. Trigger point injections for headache disorders: Expert consensus methodology and narrative review. Headache. 2014 Oct 1;54(9):1441-1459. https://doi.org/10.1111/head.12442
Robbins, Matthew S. ; Kuruvilla, Deena ; Blumenfeld, Andrew ; Charleston, Larry ; Sorrell, Michael ; Robertson, Carrie E. ; Grosberg, Brian M. ; Bender, Steven D. ; Napchan, Uri ; Ashkenazi, Avi. / Trigger point injections for headache disorders : Expert consensus methodology and narrative review. In: Headache. 2014 ; Vol. 54, No. 9. pp. 1441-1459.
@article{7eba896a5ab94922868e158d0d0bf8e5,
title = "Trigger point injections for headache disorders: Expert consensus methodology and narrative review",
abstract = "Objective/Background To review the existing literature and describe a standardized methodology by expert consensus for the performance of trigger point injections (TPIs) in the treatment of headache disorders. Despite their widespread use, the efficacy, safety, and methodology of TPIs have not been reviewed specifically for headache disorders by expert consensus. Methods The Peripheral Nerve Blocks and Other Interventional Procedures Special Interest Section of the American Headache Society over a series of meetings reached a consensus for nomenclature, indications, contraindications, precautions, procedural details, outcomes, and adverse effects for the use of TPIs for headache disorders. A subcommittee of the Section also reviewed the literature. Results Indications for TPIs may include many types of episodic and chronic primary and secondary headache disorders, with the presence of active trigger points (TPs) on physical examination. Contraindications may include infection, a local open skull defect, or an anesthetic allergy, and precautions are necessary in the setting of anticoagulant use, pregnancy, and obesity with unclear anatomical landmarks. The most common muscles selected for TPIs include the trapezius, sternocleidomastoid, and temporalis, with bupivacaine and lidocaine the agents used most frequently. Adverse effects are typically mild with careful patient and procedural selection, though pneumothorax and other serious adverse events have been infrequently reported. Conclusions When performed in the appropriate setting and with the proper expertise, TPIs seem to have a role in the adjunctive treatment of the most common headache disorders. We hope our effort to characterize the methodology of TPIs by expert opinion in the context of published data motivates the performance of evidence-based and standardized treatment protocols.",
keywords = "headache, local anesthetic, migraine, myofascial pain, tension-type, trigger point injection",
author = "Robbins, {Matthew S.} and Deena Kuruvilla and Andrew Blumenfeld and Larry Charleston and Michael Sorrell and Robertson, {Carrie E.} and Grosberg, {Brian M.} and Bender, {Steven D.} and Uri Napchan and Avi Ashkenazi",
year = "2014",
month = "10",
day = "1",
doi = "10.1111/head.12442",
language = "English (US)",
volume = "54",
pages = "1441--1459",
journal = "Headache",
issn = "0017-8748",
publisher = "Wiley-Blackwell",
number = "9",

}

TY - JOUR

T1 - Trigger point injections for headache disorders

T2 - Expert consensus methodology and narrative review

AU - Robbins, Matthew S.

AU - Kuruvilla, Deena

AU - Blumenfeld, Andrew

AU - Charleston, Larry

AU - Sorrell, Michael

AU - Robertson, Carrie E.

AU - Grosberg, Brian M.

AU - Bender, Steven D.

AU - Napchan, Uri

AU - Ashkenazi, Avi

PY - 2014/10/1

Y1 - 2014/10/1

N2 - Objective/Background To review the existing literature and describe a standardized methodology by expert consensus for the performance of trigger point injections (TPIs) in the treatment of headache disorders. Despite their widespread use, the efficacy, safety, and methodology of TPIs have not been reviewed specifically for headache disorders by expert consensus. Methods The Peripheral Nerve Blocks and Other Interventional Procedures Special Interest Section of the American Headache Society over a series of meetings reached a consensus for nomenclature, indications, contraindications, precautions, procedural details, outcomes, and adverse effects for the use of TPIs for headache disorders. A subcommittee of the Section also reviewed the literature. Results Indications for TPIs may include many types of episodic and chronic primary and secondary headache disorders, with the presence of active trigger points (TPs) on physical examination. Contraindications may include infection, a local open skull defect, or an anesthetic allergy, and precautions are necessary in the setting of anticoagulant use, pregnancy, and obesity with unclear anatomical landmarks. The most common muscles selected for TPIs include the trapezius, sternocleidomastoid, and temporalis, with bupivacaine and lidocaine the agents used most frequently. Adverse effects are typically mild with careful patient and procedural selection, though pneumothorax and other serious adverse events have been infrequently reported. Conclusions When performed in the appropriate setting and with the proper expertise, TPIs seem to have a role in the adjunctive treatment of the most common headache disorders. We hope our effort to characterize the methodology of TPIs by expert opinion in the context of published data motivates the performance of evidence-based and standardized treatment protocols.

AB - Objective/Background To review the existing literature and describe a standardized methodology by expert consensus for the performance of trigger point injections (TPIs) in the treatment of headache disorders. Despite their widespread use, the efficacy, safety, and methodology of TPIs have not been reviewed specifically for headache disorders by expert consensus. Methods The Peripheral Nerve Blocks and Other Interventional Procedures Special Interest Section of the American Headache Society over a series of meetings reached a consensus for nomenclature, indications, contraindications, precautions, procedural details, outcomes, and adverse effects for the use of TPIs for headache disorders. A subcommittee of the Section also reviewed the literature. Results Indications for TPIs may include many types of episodic and chronic primary and secondary headache disorders, with the presence of active trigger points (TPs) on physical examination. Contraindications may include infection, a local open skull defect, or an anesthetic allergy, and precautions are necessary in the setting of anticoagulant use, pregnancy, and obesity with unclear anatomical landmarks. The most common muscles selected for TPIs include the trapezius, sternocleidomastoid, and temporalis, with bupivacaine and lidocaine the agents used most frequently. Adverse effects are typically mild with careful patient and procedural selection, though pneumothorax and other serious adverse events have been infrequently reported. Conclusions When performed in the appropriate setting and with the proper expertise, TPIs seem to have a role in the adjunctive treatment of the most common headache disorders. We hope our effort to characterize the methodology of TPIs by expert opinion in the context of published data motivates the performance of evidence-based and standardized treatment protocols.

KW - headache

KW - local anesthetic

KW - migraine

KW - myofascial pain

KW - tension-type

KW - trigger point injection

UR - http://www.scopus.com/inward/record.url?scp=84964255541&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964255541&partnerID=8YFLogxK

U2 - 10.1111/head.12442

DO - 10.1111/head.12442

M3 - Article

C2 - 25168295

AN - SCOPUS:85027935704

VL - 54

SP - 1441

EP - 1459

JO - Headache

JF - Headache

SN - 0017-8748

IS - 9

ER -